Parkinson disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with Parkinson disease who visit each study site between April 1, 2025, and December 31, 2025. Patients who can provide written informed consent to participate in the study of their own free will. Patients aged between 30 and 80 years at the time of consent. Outpatient status: Limited to outpatients.
Exclusion criteria
Exclusion criteria: Patients with cognitive impairment Patients classified as stage IV or higher according to the Hoehn & Yahr scale for Parkinson disease Patients receiving device-assisted therapy for Parkinson disease Patients with orthopedic conditions such as arthritis or spinal disorders Patients with a history of stroke or peripheral nerve and muscle diseases Patients with significant vision or hearing impairments that prevent the use of a VR headset Patients deemed by the researcher to be at high risk of falling during VR based table tennis exercises Patients who have previously experienced motion sickness symptoms when using VR devices
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MDS-UPDRS part III score | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of non-motor symptoms: MDS-UPDRS Part I score Evaluation of ADL: MDS-UPDRS Part II score Evaluation of motor complications: MDS-UPDRS Part IV score Evaluation of QOL: Parkinson's Disease Questionnaire (PDQ-8) TUG (Timed Up and Go Test) Presence or absence of VR sickness | — |
Countries
Japan,Asia(except Japan)
Contacts
Takagi Hospital Department of Neurology